Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANDA 30-Month Stay Of Approval Does Not Apply If Patent Case Is Settled

Executive Summary

FDA is proposing to void the 30-month Waxman/ Hatch stay of ANDA approval in cases where patent litigation between the applicant and the innovator company is dismissed or settled.

You may also be interested in...



Paxil Generics On Hold After Court Rejects FDA “Shared Exclusivity” Policy

No more generic versions of GlaxoSmithKline's Paxil will be approved before early March under a court decision rejecting FDA's approach to "shared exclusivity.

Paxil Generics On Hold After Court Rejects FDA “Shared Exclusivity” Policy

No more generic versions of GlaxoSmithKline's Paxil will be approved before early March under a court decision rejecting FDA's approach to "shared exclusivity.

ANDA Same-Day Filers Should Share Exclusivity, Industry Lawyer Says

FDA should allow ANDA applicants who file the first Paragraph IV certifications against a patent on the same day to share 180-day exclusivity, industry attorney David Adams said at a Food & Drug Law Institute conference in Washington, D.C. April 2

Related Content

UsernamePublicRestriction

Register

PS034662

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel